Posts

Showing posts with the label Orlistat market

Global Orlistat Market (COVID-19) outbreak Business opportunities and demand, recent trends 2020-2028

Image
Orlistat is the only over the counter drug medication that is FDA approved for weight loss in connection with reduced calorie intake. The orlistat (60 mg) is designated for overweight adults aged 18 years or older in connection with a reduced-calorie, low-fat diet. However, Orlistat does not act systemically rather, it uses its therapeutic activity in the lumen of the stomach and small intestine by repressing gastric and pancreatic lipases that hydrolyze triglycerides into free fatty acids and monoglycerides. This restricts the intestine’s ability to absorb triglycerides, which are excreted fecally instead, thus inhibiting the absorption of dietary fats by approximately 30%. According to the report, orlistat 60 mg, along with a reduced-calorie, low-fat diet, may be an effective weight-loss tool for reducing metabolic risk factors associated with upper-body adiposity. The above points are some of the global orlistat market driving factors. Owing to orlistat’s mechanism of work, a decre...